|
SPCS3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.803400E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.658700E-03 |
| Normal-vs-Stage2 |
2.932500E-02 |
| Normal-vs-Stage3 |
3.866400E-01 |
| Normal-vs-Stage4 |
3.005600E-01 |
| Stage1-vs-Stage2 |
3.503800E-01 |
| Stage1-vs-Stage3 |
3.161800E-01 |
| Stage1-vs-Stage4 |
1.010410E-01 |
| Stage2-vs-Stage3 |
1.628440E-01 |
| Stage2-vs-Stage4 |
1.015990E-01 |
| Stage3-vs-Stage4 |
9.111400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.560900E-03 |
| Normal-vs-AfricanAmerican |
1.752370E-01 |
| Normal-vs-Asian |
2.260400E-01 |
| Caucasian-vs-AfricanAmerican |
1.78994999999738E-05 |
| Caucasian-vs-Asian |
9.638400E-01 |
| AfricanAmerican-vs-Asian |
6.364100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.942100E-02 |
| Normal-vs-Female |
1.662800E-03 |
| Male-vs-Female |
1.847230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.873600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.260900E-03 |
| Normal-vs-Age(61-80Yrs) |
4.483900E-02 |
| Normal-vs-Age(81-100Yrs) |
1.843000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.211830E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.779700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.809220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.612800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.265000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.915400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.745800E-01 |
| Normal-vs-Grade 2 |
1.522860E-03 |
| Normal-vs-Grade 3 |
1.578580E-01 |
| Normal-vs-Grade 4 |
5.046800E-01 |
| Grade 1-vs-Grade 2 |
3.844200E-01 |
| Grade 1-vs-Grade 3 |
7.343400E-01 |
| Grade 1-vs-Grade 4 |
5.253800E-01 |
| Grade 2-vs-Grade 3 |
2.080100E-02 |
| Grade 2-vs-Grade 4 |
1.380480E-02 |
| Grade 3-vs-Grade 4 |
5.748000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.393300E-04 |
| Normal-vs-ccB subtype |
4.399700E-02 |
| ccA subtype-vs-ccB subtype |
3.623600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.242700E-03 |
| Normal-vs-N1 |
2.128600E-01 |
| N0-vs-N1 |
8.381600E-01 |
|
|
